Preclinical development of a novel [68Ga]Ga-/[177Lu]Lu-labeled agent for PSMA-targeted imaging and therapy
Crossref DOI link: https://doi.org/10.1007/s10967-022-08301-5
Published Online: 2022-04-25
Published Print: 2022-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wu, Yitian
Zhang, Xiaojun
Zhou, Haoxi
Zhang, Jinming http://orcid.org/0000-0002-9425-5180
Text and Data Mining valid from 2022-04-25
Version of Record valid from 2022-04-25
Article History
Received: 28 January 2022
Accepted: 30 March 2022
First Online: 25 April 2022
Declarations
:
: The authors declare that they have no conflict of interest.